Related references
Note: Only part of the references are listed.2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study
Anders Holt et al.
EUROPEAN HEART JOURNAL (2021)
Association Between Oral Corticosteroid Bursts and Severe Adverse Events A Nationwide Population-Based Cohort Study
Tsung-Chieh Yao et al.
ANNALS OF INTERNAL MEDICINE (2020)
Glucocorticoids in rheumatoid arthritis: current status and future studies
Charlotte Hua et al.
RMD OPEN (2020)
The mean, variance and correlation for bivariate recurrent event data with a terminal event
Thomas H. Scheike et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2019)
COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
Pradeesh Sivapalan et al.
BMJ OPEN RESPIRATORY RESEARCH (2019)
The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants
Gregory Y. H. Lip et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation
Anthony P. Kent et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Studying Drug Safety in the Real World
Jonathan Zipursky et al.
JAMA INTERNAL MEDICINE (2018)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Social Determinants of Risk and Outcomes for Cardiovascular Disease A Scientific Statement From the American Heart Association
Edward P. Havranek et al.
CIRCULATION (2015)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
Sigrid Narum et al.
BMJ OPEN (2014)
The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier Coefficients
Daniel Westreich et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Danish National Prescription Registry
Helle Wallach Kildemoes et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Negative Controls A Tool for Detecting Confounding and Bias in Observational Studies
Marc Lipsitch et al.
EPIDEMIOLOGY (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Predicting cumulative incidence probability by direct binomial regression
Thomas H. Scheike et al.
BIOMETRIKA (2008)
Effect of oral corticosteroids on chronic warfarin therapy
Kathleen A. Hazlewood et al.
ANNALS OF PHARMACOTHERAPY (2006)
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone
N Costedoat-Chalumeau et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
